Latest Sustainability In It News

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.

Anax Metals has locked in a $3.3 million convertible note investment from Mineral Development Partners, with conditional commitments for up to $100 million to advance the Whim Creek Project and establish a Pilbara base metals hub.

Synertec Corporation reports a 7.7% revenue increase in FY25 Q3, highlights robust Powerhouse technology performance during extreme weather, and secures a US patent for its LNG Custody Transfer System.

ABx Group has discovered a new rare earth element province 52 km east of its Deep Leads resource in northern Tasmania, revealing exceptionally high grades of terbium and dysprosium critical for advanced technologies. This discovery aligns with shifting global supply dynamics amid US incentives and Chinese export restrictions.

Bio-Gene Technology Limited has raised $2.1 million through a placement and launched a Share Purchase Plan to fund critical safety studies for its flagship insecticide Flavocide®, alongside development of Qcide and strategic initiatives.

Northern Star Resources has completed its acquisition of De Grey Mining, issuing new shares to De Grey shareholders and preparing to integrate the promising Hemi gold project into its portfolio.

Unico Silver Limited has reported exceptional high-grade silver intercepts from its Phase 2 drilling at Cerro Leon, confirming multiple new discoveries and launching an expanded Phase 3 program to upgrade resources and explore deeper polymetallic zones.

Northern Star Resources has completed its acquisition of De Grey Mining, issuing new shares and preparing to delist De Grey from the ASX, marking a strategic expansion into Western Australia's Hemi gold project.

Enlitic, Inc. has launched a two-tranche institutional placement to raise A$10 million, underpinning its strategic collaboration with GE HealthCare and fueling expansion in AI-enabled medical imaging data migration.

Anagenics Ltd has reported a significant earnings turnaround in 3Q25 following a strategic business restructure, alongside securing a multi-year royalty agreement worth $4.4 million with York Street Brands.

Neurizon Therapeutics has announced the successful completion of its Open-Label Extension study for NUZ-001 in ALS, revealing significant survival benefits and strong tolerability. The company is on track to release top-line results in Q3 2025 and advance to a pivotal Phase 2/3 trial.

Endeavour Group reports a challenging Q3 with Retail sales down 3.1% and Hotels up 5.1%, while announcing Jayne Hrdlicka as incoming CEO and maintaining capital and finance guidance.